Men who got the largest share of their calories from ultra-processed foods reported prostate cancer at higher rates than men who ate the least, according to an analysis of 17,024 US men published in The American Journal of Medicine. The finding lands in a country where these products supply more than half of adults' calories, with published estimates ranging from about 53 percent in recent federal survey data to nearly 60 percent, the figure the study authors cite.
The headline number is roughly 30 percent higher, but the details matter. In unadjusted analyses, men in the three higher-consumption groups showed a 29 percent greater risk and men in the two highest groups showed a 30 percent greater risk. After adjustment, those figures were 27 percent and 31 percent. Men in the highest group alone showed a possible 34 percent higher risk, though it did not reach statistical significance.
For men in their thirties and forties reading this over breakfast, the practical question is what to do with a number like that. The honest answer is that this study supports general dietary caution, not a screening decision or a specific food ban. Its design cannot establish that ultra-processed food causes prostate cancer, and the researchers say analytic studies are needed to test the hypothesis.
The Numbers Behind the Headline
Researchers at Florida Atlantic University's Charles E. Schmidt College of Medicine used data from the National Health and Nutrition Examination Survey covering 2003 through 2023. They estimated each man's ultra-processed food intake from two 24-hour dietary recalls, classified foods using the NOVA system, and sorted participants into four groups ranging from below about 20 percent of calories to above 44 percent.
The comparisons in the study abstract are reported with p-values close to the conventional threshold, and the estimate for the highest-consumption group alone falls on the wrong side of that threshold. The authors attribute that to the smaller number of prostate cancer cases in that group. The food category itself covers familiar products: soft drinks, packaged snacks, sweetened breakfast cereals and processed meats.
Prostate cancer is not a marginal concern. The American Cancer Society estimates more than 333,000 US men will be diagnosed in 2026 and more than 36,000 will die of the disease, figures cited in the university's announcement of the findings.
Design Limits That Shape the Findings
These limitations belong near the top, not buried at the end. Prostate cancer status in this analysis was defined by self-report rather than by pathology records or a cancer registry. Diet was captured through two single-day recalls, which is a thin snapshot of a lifetime eating pattern. And the analysis is observational and cross-sectional, meaning diet and diagnosis were measured in the same individuals rather than tracked over time.
That last point is the crucial one. A man diagnosed with prostate cancer may have changed how he eats after diagnosis, in either direction, and this design cannot separate that from a dietary effect that preceded the disease. The authors also flag confounding they could not measure, including family history, prostate-specific antigen screening and physical inactivity, each of which independently shapes who gets diagnosed.
Senior author Charles H. Hennekens, the First Sir Richard Doll Professor of Medicine and Preventive Medicine at Florida Atlantic University, framed the finding cautiously in the university announcement. "These findings add to emerging evidence that UPFs have major adverse health effects," he said, adding that large-scale observational studies and randomized trials are needed to test the hypothesis properly. That is guidance about overall diet quality, not a claim of proven causation.
Where the Evidence Already Disagrees
Readers deserve to know that this finding does not sit comfortably alongside all prior research. A systematic review and meta-analysis published in the journal Cancers in late 2024 pooled six studies and found no significant association between ultra-processed food intake and prostate cancer risk, with a pooled relative risk of 1.02. It also found a non-significant trend toward higher mortality. A separate pooled analysis of cancer sites reached a similar conclusion, linking high intake to colorectal and breast cancer but not to prostate cancer.
That disagreement is not a reason to dismiss the new study, nor is it a reason to accept it uncritically. It is a signal that the prostate cancer question specifically remains unresolved, even as the evidence linking ultra-processed foods to cardiometabolic harm has grown steadily stronger. MedicalDaily has previously covered research using blood metabolomics to measure ultra-processed food intake more objectively than self-reported diets allow, an approach that may eventually settle questions like this one.
Current medical guidance has not changed. No professional body has revised prostate cancer screening or prevention recommendations based on this analysis.
Practical Changes Backed by Broader Nutrition Research
The steps supported here are the same ones supported by the broader body of nutrition evidence, which is a reason to take them seriously rather than to shrug. Shifting away from soft drinks and packaged snacks toward whole and minimally processed foods is the change with the broadest support, and it rests on cardiovascular and metabolic evidence that does not depend on how the prostate cancer question is resolved.
Cost and access are part of the difficulty. Study co-author Timothy De Ver Dye, professor and chair of the university's Department of Population Health, noted in the same announcement that reducing consumption of these products is a complex public health challenge given their prevalence and accessibility, and that many patients face real barriers to affording healthier options. Ultra-processed foods are often cheaper per calorie, shelf-stable, and available in neighborhoods where fresh produce is not. Advice that ignores this does not work.
Men with a family history of prostate cancer, Black men, and men over 50 should discuss screening with a clinician regardless of diet, since those risk factors are established and dietary patterns are not. Nobody should interpret this study as a reason to delay or skip a conversation about prostate-specific antigen.
Larger prospective studies that track diet before diagnosis and confirm cancers through medical records would move this from association toward evidence of causation. Until those exist, the reasonable posture is to improve diet quality for reasons that are already well established, and to treat the prostate cancer link as an open question.
Key Questions Answered
What did the study find? Among 17,024 US men, those consuming more ultra-processed food reported prostate cancer at higher rates than the lowest-consumption group. Adjusted estimates were 27 percent and 31 percent higher for the combined higher-intake groups.
Does this prove ultra-processed food causes prostate cancer? No. This is an observational, cross-sectional analysis of national survey data. It identifies an association but cannot establish causation, and the researchers say that analytic studies are needed.
What counts as ultra-processed food? Under the NOVA classification, ultra-processed foods include industrially formulated products such as soft drinks, packaged snacks, sweetened cereals, and processed meats. Whole and minimally processed foods fall outside the category.
What are the main weaknesses of the study? Prostate cancer was self-reported rather than confirmed through records, diet was captured from two single-day recalls, the design is cross-sectional, and family history and screening history were not accounted for.
Was every result statistically significant? No. The estimate for the highest-consumption group alone, a possible 34 percent higher risk after adjustment, did not reach statistical significance.
Do other studies agree? Not entirely. A 2024 meta-analysis of six studies found no significant association between ultra-processed food intake and prostate cancer risk, which is why this question remains open.
Should men change their screening plans? No. Screening decisions should be based on age, family history, race, and clinician guidance. This study does not change screening recommendations.
